Results 141 to 150 of about 2,031,294 (377)

Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer   +14 more
wiley   +1 more source

Synthesis of Diastereomeric 2,6-bis{[3-(2-Hydroxy-5-substitutedbenzyl)octahydro-1H-benzimidazol-1-yl]methyl}-4-substituted Phenols (R = Me, OMe) by Mannich-Type Tandem Reactions

open access: yesMolbank
The synthesis and characterization of two novel diastereomeric Mannich bases was carried out from the reaction of the cyclic aminal (2R,7R,11S,16S)-1,8,10,17-tetraazapentacyclo[8.8.1.1.8,170.2,70.11,16]icosane 1 and p-cresol 2a and 4-methoxyphenol 2b in ...
Diego Quiroga   +2 more
doaj   +1 more source

Investigation of oscillating cascade aerodynamics by an experimental influence coefficient technique [PDF]

open access: yes
Fundamental experiments are performed in the NASA Lewis Transonic Oscillating Cascade Facility to investigate the torsion mode unsteady aerodynamics of a biconvex airfoil cascade at realistic values of the reduced frequency for all interblade phase ...
Buffum, Daniel H., Fleeter, Sanford
core   +1 more source

Changes in Immune‐Inflammation Status and Acute Ischemic Stroke Prognosis in Prospective Cohort

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Inflammation is a critical risk factor for poor outcomes in cerebral infarction. Prior studies focused primarily on baseline inflammation status, neglecting dynamic longitudinal changes. We try to investigate the association between immune‐inflammation status alterations and stroke prognosis, and evaluated three systemic biomarkers'
Songfang Chen   +11 more
wiley   +1 more source

Parámetros inductivos y capacitivos equivalentes de fase y de secuencia de las líneas de transmisión conectadas en cascada; Inductive and capacitive equivalent parameters of phase and sequence of transmission lines connected in cascade.

open access: yesRevista Científica de Ingeniería Energética, 2011
En el Sistema Electro Energético Nacional (SEN) existen líneas de transmisión a 110 y 220 kV conectadas en cascada o en serie que, por tramos que poseen diferentes estructuras, conductores, flechas, resistividades del terreno, etc ...
Héctor Silvio Llamo Laborí
doaj  

Olink Proteomics Analysis Reveals Heterogeneous Responses to FcRn Blockade in Anti‐AChR Antibody‐Positive Myasthenia Gravis: FGF‐19 as a Novel Biomarker

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aimed to systematically observe the clinical manifestations, immune cell subsets, and dynamic changes in serological indicators in patients with myasthenia gravis (MG) before and after efgartigimod (EFG) treatment. Methods We analyzed the baseline data, laboratory parameters, and lymphocyte subset proportions in MG ...
Tiancheng Luo   +9 more
wiley   +1 more source

Design of High-frequency Module for Cascaded Power Electronic Transformer

open access: yesKongzhi Yu Xinxi Jishu, 2017
Based on the principle analyses and comparison of the main circuit topologies of high voltage power electronic transformer(PET), a high-frequency module for high-voltage cascaded PET was proposed.
LUO Jianbo   +3 more
doaj  

Daratumumab Treatment for Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): A Case Report

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an immune‐mediated neuropathy featuring progressive weakness, sensory deficits, and areflexia. While corticosteroids, intravenous immunoglobulin, and plasmapheresis are effective first‐line immunotherapies, a subset of patients remains treatment‐refractory.
Xueyu Zhang   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy